FIELD: medicine.
SUBSTANCE: method involves intraperitoneal injections of medicinal preparations to mice within 12 days, including injections to SHR mice of Benzedrine and haloperidol alternated every second day with six injections of each preparation. Benzedrine is injected 10 mg/kg once a day in the morning at 10.00. Haloperidol is introduced 5 mg/kg once a day in the morning at 10.00.
EFFECT: possibility to simulate chronically progressive clinical course type.
2 ex, 5 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ADAMANTYL DERIVATIVES OF BENZIMIDAZOLE, HAVING ANTIPARKINSONIAN ACTIVITY | 2023 |
|
RU2820315C1 |
| AGENT FOR PREVENTION AND CORRECTION OF MOTOR, EXTRAPYRAMIDAL DISTURBANCES INDUCED BY NEUROLEPTICS | 2009 |
|
RU2421222C2 |
| METHOD OF PARKINSON DISEASE TREATMENT | 1994 |
|
RU2057529C1 |
| QUINAZOLIN-4(3H)-ONE DIMETHOXYBENZYLSULFO DERIVATIVE WITH ANALGESIC, ANTIPARKINSONIAN, ANXIOLYTIC, PSYCHOSTIMULATING ACTIVITY | 2021 |
|
RU2758333C1 |
| REMEDY POSSESSING NEUROLEPTIC PROPERTIES | 1992 |
|
RU2042355C1 |
| ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
| NEW THERAPEUTIC COMBINATIONS OF MIRTAZAPINE AND ANTIPSYCHOTIC AGENTS FOR TREATMENT OR PROPHYLAXIS OF PSYCHOTIC DISORDERS | 1998 |
|
RU2222330C2 |
| ANTIPSYCHOTIC AGENT AND METHOD FOR PREPARING IT | 2013 |
|
RU2519761C1 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| AGENT EXHIBITING ANTIPSYCHOTIC ACTIVITY | 2008 |
|
RU2411248C2 |
